Top Markets
#1 Nesa Nesa +816.77%
#2 Cortex Cortex +68.49%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.50%
#4 QuantixAI QuantixAI +23.90%
#5 EXOD EXOD +22.78%
#6 BSquared Network BSquared Network +19.70%
#7 Pons Pons +18.22%
#8 Instadapp Instadapp +16.92%
#9 Magma Finance Magma Finance +12.52%
#10 OpenEden OpenEden +11.84%
Coin of the day
Nesa Nesa
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

002294
Classificação em ações #3531
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Preço da ação
$4.64
Valor de mercado
$5.17B
Variação (1 dia)
0.22%
Variação (1 ano)
-37.54%
País
CN
Negociar Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Categoria

Healthcare
Histórico de desdobramentos de ações de Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
As ações Shenzhen Salubris Pharmaceuticals Co., Ltd. (símbolo: 002294) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 26, 2026.
Uma ação 002294 comprada antes de Aug 26, 2026 equivaleria hoje a 0 ações 002294.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 3 x4
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 3 x20
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 0 -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 6 x20
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 0 -
CH